BRIEF-BioProspect completes due diligence on Invatec/Heartlink'S diagnostic heart rate variability technology

Thu, 20 Mar - 8:44am

March 20 (Reuters) - BioProspect Ltd BPO.AX :

* Successful completion of technical due diligence

* Completion of technical due diligence on Invatec/Heartlink'S diagnostic heart

rate variability technology

* Source text for Eikon News Search ID:nASXb9sVDv

((For more news, please click here BPO.AX ))

((Bangalore Newsroom; +91 806749 1130))

URN:

urn:newsml:reuters.com:20140319:nWNBS00DNI:6

Topics:

LEN RTRS AU CMPNY PHMR DRU HECA MRCH BLR ASIA

Public links